Showing 6361-6370 of 20414 results for "".
Lifestyle Factors to Aid in Lowering Cholesterol
https://reachmd.com/programs/lipid-luminations/lifestyle-factors-to-aid-in-lowering-cholesterol/3506/Host Dr. Larry Kaskel welcomes Dr. Penny Kris-Etherton, PhD, RD to Lipid Luminations. Dr. Kris-Etherton is a distinguished professor of nutrition at Penn State University. The discussion will cover what health care professionals can do to increase cholestrol awareness in the general population as wEncouraging CPR Participation from Bystanders
https://reachmd.com/programs/clinicians-roundtable/encouraging-cpr-participation-from-bystanders/2927/In cases of out-of-hospital sudden cardiac arrest, bystanders are now formally encouraged to bypass full cardiopulmonary resuscitation (CPR), in favor of continuous chest compressions. This instruction comes following a March 2008 scientific advisory published in the journal Circulation. GivenFrom Data to Decision: Patient Selection and Real-World Application
https://reachmd.com/programs/cme/from-data-to-decision-patient-selection-and-real-world-application/60855/Experts explore emerging evidence and multidisciplinary integration of perioperative immunotherapy for resectable, locally advanced HNSCC.Face Value with Modern Aesthetics: Burnout’s Hidden Aging Effects
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-burnouts-hidden-aging-effects/60947/Jennifer Fleming, NP, examines how chronic stress and burnout can accelerate visible facial aging. From hormonal decline and inflammation-driven collagen loss to treatment strategies that address root causes beyond injectables, this conversation explores the science behind the “tired face” and whatAdvancing Uveitis Care: Emerging Challenges and Research Opportunities
https://reachmd.com/programs/eye-on-ocular-health/uveitis-care-challenges-research/56394/Despite advances in diagnosis and treatment, up to 40% of uveitis cases remain without a clear cause. Dr. Steven Yeh joins us to explain how emerging diagnostic technologies, evolving insights into retinal inflammation, and the growing impact of infectious pathogens are reshaping our approach to uveUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
https://reachmd.com/programs/clinicians-roundtable/using-ftir-to-support-accurate-tissue-assessment-in-colorectal-surgery/36482/Fourier Transform Infrared (FTIR) spectroscopy is emerging as a powerful tool for distinguishing cancerous from noncancerous tissue during colorectal cancer surgery. In a recent study, Drs. Heather Allen and Ran Li leveraged a broad dataset from multiple sources to identify and validate biomarkers—mNavigating Vaccine Communication: A Medical Affairs Perspective
https://reachmd.com/programs/maps-chats/vaccine-communication-medical-affairs/56810/At the intersection of expertise, strategy, and collaboration, medical affairs professionals are translating vaccine science into meaningful and actionable insights for healthcare providers. In this candid conversation from the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. MatThe Emergence of Targeted Therapies for Prurigo Nodularis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/the-emergence-of-targeted-therapies-for-prurigo-nodularis/48775/Christopher Bunick, MD, FAAD, discusses the importance of acknowledging prurigo nodularis as a distinct disease with its own molecular and transcriptomic features distinguishing it from atopic dermatitis, and how targeting the IL-31 receptor can change the game.Advances in Psoriasis Treatment: Selecting the Right Biologic Therapy
https://reachmd.com/programs/clinicians-roundtable/advances-in-psoriasis-treatment-selecting-the-right-biologic-therapy/36366/Biologic therapies have helped significantly improve outcomes and quality of life for patients with psoriasis. With several IL-17 and IL-23 inhibitors now available, choosing between biologics often depends on the dermatologist’s experience, the patient’s needs, and potential side effects. Hear Dr.Putting Patients First: Personalized Care in Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/putting-patients-first-personalized-care-in-metastatic-breast-cancer/36435/Metastatic breast cancer treatment isn't one-size-fits-all. Providers must carefully balance clinical outcomes, toxicity, and patient lifestyle and preferences. Dr. Giancarlo Moscol joins Ms. Ashley Baker to outline a structured, three-tiered decision-making process that weighs treatment efficacy, s